Hydrogen Sulfide

Hydrogen Sulfide

SCHEMBL27744648

CC(c1ccccc1)C(F)(F)F.S

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.39
TRPA1 O75762 2/20 0.39
RIPK1 Q13546 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA2C P18825 1/20 0.38
CYP2D6 P10635 1/20 0.38
LMNA P02545 1/20 0.38
HIF1A Q16665 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
CACNA1F O60840 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
OPRK1 P41145 1/20 0.36
CACNA1D Q01668 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852044 0.97 TAAR1 (0.41) TAAR1RIPK1ADRA2AADRA2CCYP2D6
SCHEMBL1416399 0.97 TAAR1 (0.41) TAAR1RIPK1ADRA2AADRA2CCYP2D6
SCHEMBL8090925 0.97 TAAR1 (0.41) TAAR1RIPK1ADRA2AADRA2CCYP2D6
SCHEMBL27744643 0.85 ALDH1A1 (0.37) LMNAKDM4EALDH1A1
SCHEMBL19706344 0.84 PTGS2 (0.48) ALDH1A1
SCHEMBL24682880 0.80 HTR2A (0.42) TAAR1ADRA2CLMNASIGMAR1ADRA1A
SCHEMBL13563587 0.80 RIPK1 (0.43) TAAR1RIPK1ADRA2AADRA2CCYP2D6
SCHEMBL12346316 0.79 LTA4H (0.47) ALDH1A1
SCHEMBL12354676 0.79 LTA4H (0.47) ALDH1A1
SCHEMBL16785292 0.77 PTPN5 (0.41) CYP2D6LMNAHIF1AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101421243-B Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO KG 2012-05-30 CN disclosed
CN-101421243-A Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO KG (DE) 2009-04-29 CN disclosed